These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4405453)

  • 1. Metabolism in vitro of 5,5-diphenylhydantoin.
    Gabler WL; Hubbard GL
    Biochem Pharmacol; 1972 Nov; 21(22):3071-3. PubMed ID: 4405453
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
    Kutt H; Verebely K
    Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.
    Harbison RD; Becker BA
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):573-81. PubMed ID: 5143597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diphenylhydantoin degradation in the human placenta in an experiment on placentas perfused by extracorporeal circulation].
    Serówka E; Henneberg M; Zrubek H; Oleszczuk J
    Ginekol Pol; 1982; 53(1-2):1-8. PubMed ID: 7106609
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.
    Hansen JM; Kristensen M; Skovsted L
    Epilepsia; 1968 Mar; 9(1):17-22. PubMed ID: 4386877
    [No Abstract]   [Full Text] [Related]  

  • 8. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
    Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
    J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies on the metabolism of 17-epitestosterone and testosterone in slices and cell fraction of rat liver].
    Stárka L; Breuer H
    Hoppe Seylers Z Physiol Chem; 1968 Dec; 349(12):1698-710. PubMed ID: 4387677
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of 5,5-diphenylhydantoin (DPH) in nonpregnant and pregnant Rhesus monkeys.
    Gabler WL; Hubbard GL
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):72-91. PubMed ID: 4199058
    [No Abstract]   [Full Text] [Related]  

  • 12. Dicoumarol-induced diphenylhydantoin intoxication.
    Hansen JM; Kristensen M; Skovsted L; Christensen LK
    Lancet; 1966 Jul; 2(7457):265-6. PubMed ID: 4161425
    [No Abstract]   [Full Text] [Related]  

  • 13. Salsolinol, an alkaloid derivative of dopamine formed in vitro during alcohol metabolism.
    Yamanaka Y; Walsh MJ; Davis VE
    Nature; 1970 Sep; 227(5263):1143-4. PubMed ID: 4317952
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridine nucleotides in the thyroid gland. 8. Effect of thyroid-stimulating hormone on nicotinic acid-14C incorporation into NAD, NADP and NADPH.
    Oka H; Field JB
    Endocrinology; 1967 Dec; 81(6):1291-6. PubMed ID: 4383629
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins.
    Pantarotto C; Arboix M; Sezzano P; Abbruzzi R
    Biochem Pharmacol; 1982 Apr; 31(8):1501-7. PubMed ID: 7092941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model describing the disposition of phenytoin in isolated rat hepatocytes.
    Morais JA; Wagner JG
    Biopharm Drug Dispos; 1984; 5(4):357-76. PubMed ID: 6525443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new metabolite of 5,5-diphenylhydantoin (Dilantin).
    Chang T; Savory A; Glazko AJ
    Biochem Biophys Res Commun; 1970 Feb; 38(3):444-9. PubMed ID: 5443691
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of an inhibitor of glucuronide formation on elimination kinetics of diphenylhydantoin in rats.
    Levy G; Ashley JJ
    J Pharm Sci; 1973 Jan; 62(1):161-2. PubMed ID: 4682924
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin.
    Haque N; Thrasher K; Werk EE; Knowles HC; Sholiton LJ
    J Clin Endocrinol Metab; 1972 Jan; 34(1):44-50. PubMed ID: 5008232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.